Paul K. Audhya, CHIEF MEDICAL OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 2,239 shares at $26.78 ($60K) on 2026-05-26, disclosed to the SEC on 2026-05-27.
Seasonal sale ($60k) by CHIEF MEDICAL OFFICER — this insider has traded KALV in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KALV | SELL | 2026-04-20 | $54K | — | Filing → |
| KALV | SELL | 2026-02-24 | $167K | — | Filing → |
| KALV | SELL | 2026-02-19 | $17K | — | Filing → |